Tag: NSPR

Blue Horseshoe Stocks: USRM, ICLD Follow-ups & More

U.S. Stem Cell, Inc. USRM
We’ve been tracking USRM very closely over the past few weeks, since initially mentioning it on the morning of February 27th and witnessing a huge subsequent increase( .014-.0545,+289%). We monitored the consolidation off of that high down to .0175, and once again signaled that it was time to give it our close attention last week on the 15th.

The rebound that has since occurred has been very nice, with USRM surging back to .053 yesterday, a jump of 203% over its .0175 swing low. So that’s twice now, in the span of less than a month that we’ve seen a 200% move out of this play. We’re obviously going to continue following it, with the type of price action and volatility we’ve seen so far, USRM is currently a swing-trader’s paradise.

InterCloud Systems, Inc. ICLD

We also had a ringer with ICLD earlier this month, when we signaled it on the 2nd before the stock took off from a low of .0157 to a high .0985, a 527% rip. After watching it consolidate off of those highs for a few days, re brought it back to readers’ attention in yesterday’s premarket report, and our attempted timing of the reversal couldn’t have worked any better.

From an early low of .0302, the stock steadily made its way up to a high .0439 shortly after 1PM, for an intraday spike of 45% and held more than half of its daily gains into the close, so this one will also remain on our watchlist in coming sessions.

Northern Dynasty Minerals, Ltd. NAK

We tagged NAK last Thursday after watching the stock search out a bottom for quite awhile. The stock did bounce, and has thus far posted a 31% increase, reaching 1.58 yesterday and closing just a tick below at 1.57, as you can see on the included snapshot.

Also on the chart, we can see that the RSI is on the verge of cracking the 50-line, and the MACD has just crossed in a bullish manner. Conditions seem to be ripe for the possibility of a continued rebound, so we’ll pay close attention to NAK in sessions to come.

Extended Watchlist:
IDOI, NSPR, FCEL, HTBX, ESPR, CLRB

Blue Horseshoe Stocks: TPIV Recap, PZOO News & More

TapImmune, Inc. TPIV

Despite already being on one heck of a run, as we were stating in yesterday’s morning report, TPIV ended up having another landmark session in which it would surge to its highest PPS in almost a year.

The stock posted an early low of 1.20 before breaking out to 1.71, which registered as an intraday spike of 43% and occurred on heavy volume. TPIV also took the title of most actively-traded stock on the OTC for yesterday’s session, with shares changing hands 3,388 times.

We want to congratulate anyone who’s been tracking TPIV along with us recently; the total increase we’ve now observed in just eight sessions is equal to 137% (.72-1.71).

Yesterday’s continued uptrend was aided by the following PR:
TapImmune Reports Robust Immune Responses Generated in 19 of 20 Evaluable HER2/neu Breast Cancer Patients (Tue, Jun 23)

Pazoo, Inc. PZOO

Those of our subscribers that have joined our ranks in the past few weeks will need a little bringing up to speed on PZOO. We introduced this play at the beginning of April, and tracked it over an epic run from .0049 to .0204, which amounted to a 316% swing.

It has been nearly four weeks since we touched base with this play, and with a fresh PR released this morning, we think now would be a good time  to take another look. The stock has done well maintaining support throughout the month of June, trading in a channel between .009 to .011, holding a good bit of the advances we witnessed earlier in the Spring.

The storyline we’ve been following on PZOO of its 40% ownership in MA & associates, a Nevada-based marijuana testing agency, just got a whole lot more interesting with PZOO officially announcing that it has acquired the remaining 60% stake:

WHIPPANY, N.J., June 24, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks: PZOO) is pleased to report that on Wednesday, June 3, 2015,  Pazoo acquired the remaining 60% of MA & Associates, LLC in exchange for 900,000 shares of Pazoo’s Series C. Preferred stock. This now makes MA & Associates, LLC a 100% wholly-owned subsidiary of Pazoo. >>FULL PR

The MaryJane Group, Inc. MJMJ

MJMJ was among several stocks we tagged for potential upcoming bottom-plays at the end of last week, and while it did take the call an extra session to materialize, it did end up making that rebound yesterday.

The stock traded in a range from .0027-.0038; which marks an intraday swing of 41% on more than twice the average monthly volume. We’ll continue to monitor activity in the stock as the week progresses.

Under Armour, Inc. UA – Options

Yesterday morning, we updated readers as to the performance of the 07/31 $84 Calls that we initially alerted on Friday. From our observed low of 2.76, these contracts pushed further upward yesterday, extending to a new high of 4.20.

That pushes the overall range we’ve witnessed in just a two-session span to a respectable 52% We’ll continue to stay attuned to the activity as long as UA continues to perform well.

Extended Watchlist:
CPXX, NSPR, MEET, GBSN,

Blue Horseshoe Stocks: Options Update & Much More

Amedica Corp. AMDA

After providing us with the chance for intraweek gains of 61% last week, as we were mentioning in yesterday’s morning report, AMDA turned in another healthy performance for the day.

From a morning low of .58, the stock pressed to a new high of .70; a 21% intraday move, and this morning the stock is gapping up once again. As of this morning’s premarket high, the total range we’ve now observed in AMDA in just a week’s time stands at 102% from last Tuesday’s low of .3851.

Yesterday’s solid showing also marked the fifth consecutive trading day that AMDA managed to register higher lows and higher highs. We’ll continue to track its activity as the week progresses. A dip-and-rip off of this morning’s new high is a distinct possibility.

Under Armour, Inc. UA – Options Update

UA was a point of focus for us on Friday morning, at which time we submitted a medium-term options idea for the stock, namely the 07/31 $84 Calls. We wanted to provide an update on the subsequent performance of those contracts, which managed a notable increase between Friday and yesterday.

From a low of 2.76, the July $84’s have traded as high as 3.53 thus far. That hashes out to total possible gains of 28% over just a couple of trading sessions. With plenty of time left until expiration, we’ll be sure to keep a slot reserved for those contracts from this point forward.

TapImmune, Inc. TPIV

We’ve been tracking TPIV for nearly two weeks now. We tagged it for the first time on June 10th, and we slipped a reminder into Friday’s report as well.

We certainly hope those alerts caught someone’s attention, because TPIV has certainly caught ours; yesterday’s high of 1.23 represented a 28% jump from the low following Friday’s alert (.962) and an overall increase of 71% from the low following our initial alert (.72).

Sipp Industries, Inc. SIPC

SIPC is catching our attention this morning after announcing the addition of “Hemp co-packing, storage, distribution, and private label solutions to product offering.” in an early PR. It caused us to take notice of the chart, which is currently boasting an attractive setup with regard to its potential as a bottom-play. We’re going to keep a close eye on SIPC as we head into mid-week.

Extended Watchlist:
PHMD, BIND, NSPR, TBIO, BBRY

Blue Horseshoe Stocks: Recap of Yesterday’s Huge Session

Our first order of business today will be to go over the wealth of premium gain opportunities contained in yesterday’s premarket report. We had not one, but three of our selections make major moves, not to mention a couple of other modest gainers.

Prima BioMed, Ltd. PBMD

Quickly shooting to the top of our watchlist was PBMD. Its performance was exhilarating to behold as the stock went on an absolute tear from a low of 2.08 on up to 6.48. It marked an epic intraday run which produced total possible gains on the order of 211%

The move occurred on monstrous volume to the tune of nearly 62X the 3-month average, and stemmed largely from some positive results on one of the company’s trial drugs, announced Tuesday. >> READ PR

With the kind of momentum we’ve witnessed building up in just a single session from PBMD, we’re very interested to continue to follow the price action. A significant dip-and-rip scenario could soon present itself.

IsoRay, Inc. ISR

We also tagged ISR in yesterday’s extended watchlist, and it too shot up rapidly with the help of optimistic results from one of its own drug trials. From an early low of 1.86, the stock ran up as high as 3.38, carving out an intraday rip of 82%

This morning, we saw ISR go as high as 4.00 in premarket trading, extending the overnight range on this play to an eyebrow-raising 115%

We’ll certainly be monitoring this stock as we cruise into week’s end. Like PBMD, we’ll be on the lookout for profit-taking to possibly put a dip-and-rip scenario into effect.

Holiday Island Holdings, Inc. HIHI

In our closing thought from yesterday’s report, we called attention to a massive one-third share reduction being enacted by HIHI, and were extremely pleased to have done so. From a low of .0015, the stock broke out to hit .00265; a healthy move totaling 76%

We then saw it pull back into the close, but we’re not finished monitoring the stock by any means. We caught wind of a promotion (in which we are not involved) going out on HIHI this morning, which could provide us with an impeccably-timed boost to extend our profits as we look to take them off the table.

In light of the monumental performances we’ve seen out of news-fueled pharma plays this week, we’ve dug up a few more this morning for us to pin to our watchlists:

Calithera Biosciences, Inc. CALA

Actinium Pharmaceuticals, Inc. ATNM

Ampio Pharmaceuticals, Inc. AMPE

Extended Watchlist:
NSPR, CTP, AVEO

Blue Horseshoe Stocks: FRO Review & More

Frontline Ltd. FRO

FRO has definitely turned out to be one of our biggest success stories of the past several weeks. Just to refresh people’s memories, we caught this play coming off of some of its lowest prices of the year back on December 1st. Our observed low on FRO was 1.33 at that time, and in two huge upward moves the stock has traversed quite a bit of territory since then.

Yesterday FRO achieved a high of 5.05, which marks a total increase of 280% in just under six weeks! As we did after the initial push, we could now see a possible dip-and-rip scenario. We’ll remain interested provided the stock maintains support at or above the $3-area on the pullback.

As we can see on the chart above, there is a potential Golden Cross in the making, and with tens of millions of barrels of crude to be held on tankers over the next few months given the current oil landscape, this may not be the last time we point to big moves from FRO.

BARCHART.COM is currently giving FRO a “100% Buy” rating.

Twitter, Inc. TWTR – Options

Following up on one of the options ideas we were mulling over on TWTR last week; the TWTR February $40 Calls. When we first mentioned them last Wednesday (Saw a low of 2.15), we mentioned that they “could be in line for significant gains if TWTR continues to recover off of recent lows” and we did in fact see some substantial movement.

Those Feb. $40’s hit a high of 3.70 during the day yesterday, for an overall increase of 72% in a span of just four sessions! Even further gains could be forthcoming provided TWTR continues the current trend, so we’ll want to reserve it a slot on our watchlist as we head into mid-week.

Extended Watchlist:
NLST, CTIC, NSPR, RSH, ELX, ANV

Get Our FREE Daily Reports!

SUBSCRIBE